A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice

Experimental Dermatology

Volumn 22, Issue 10, 2013, Pages 669-671

  Arai, Iwao ^a,b   Tsuji, Minoru ^a   Takeda, Hiroshi ^a   Akiyama, Nobutake ^b   Saito, Saburo ^b  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IL 31; Itch; Pruritogen; Scratch; Serotonin

Indexed keywords

INTERLEUKIN 31; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; MOUSE; NONHUMAN; PRURITUS; SCRATCHING; SINGLE DRUG DOSE;

IL-31; ITCH; PRURITOGEN; SCRATCH; SEROTONIN;

ANIMALS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; INTERLEUKINS; MICE; MICE, INBRED BALB C; PRURITUS; SEROTONIN; SKIN; SKIN DISEASES; TIME FACTORS;

EID: 84884719865     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12222     Document Type: Article

References (26)

1. Hanifin J M, Rajka G. Acta Derm Venereol 1980: 92: 44-47.
2. Wahlgren C F. J Dermatol 1999: 26: 770-779.
3. Dillon S R, Sprecher C, Hammond A et al. Nat Immunol 2004: 5: 752-760.
4. Takaoka A, Arai I, Sugimoto M et al. Eur J Pharmacol 2005: 516: 180-181.
5. Takaoka A, Arai I, Sugimoto M et al. Exp Dermatol 2006: 15: 161-167.
6. Takano N, Arai I, Kurachi M. Eur J Pharmacol 2003: 471: 223-228.
7. Matsuda H, Watanabe N, Gregory P G et al. Int Immunol 1997: 9: 461-466.
8. Hashimoto Y, Arai I, Nakanishi Y et al. Life Sci 2004: 76: 783-794.
9. Inagaki N, Nagao M, Igeta K et al. Skin Pharmacol Appl Skin Physiol 2001: 14: 87-96.
10. Yamaguchi T, Nagasawa T, Satoh M et al. Neurosci Res 1999: 335: 77-83.
11. Akiyama N, Ohno Y, Fukuda T et al. BBRC 2009: 381: 612-618.
12. Takano N, Arai I, Hashimoto Y et al. Eur J Pharmacol 2004: 495: 159-165.
13. Arai I, Takaoka A, Hashimoto Y et al. Eur J Pharmacol 2007: 556: 207-214.
14. Takano N, Arai I, Hashimoto Y et al. Eur J Pharmacol 2004: 495: 159-165.
15. Hiroi J, Sengoku T, Morita K et al. Jpn J Pharmacol 1998: 76: 175-183.
16. Takano N, Arai I, Kurachi M. Br J Dermatol 2006: 154: 426-430.
17. Hashimoto Y, Arai I, Takano N et al. Br J Dermatol 2006: 154: 28-33.
18. Hashimoto Y, Takaoka A, Sugimoto M et al. Exp Dermatol 2011: 20: 820-825.
19. Grimstad O, Sawanobori Y, Vestergaard C et al. Exp Dermatol 2009: 18: 35-43.
20. Ezzat M H, Hasan Z E, Shaheen K Y. J Eur Acad Dermatol Venereol 2011: 25: 334-339.
21. Kim S, Kim H J, Yang H S et al. Ann Dermatol 2011: 23: 468-473.
22. Szegedi K, Kremer A E, Kezic S et al. Exp Dermatol 2012: 21: 431-436.
23. Schmelz M. Itch: Basic Mechanisms and Therapy. In: Yoshipovitch G, Greaves M W, Fleisher A B, McGlone F eds. New York: Marcel Decker Inc., 2004:147-160.
24. Akiyama T, Merrill A W, Carstens M I et al. J Neurosci 2009: 20: 6691-6699.
25. Inagaki N, Igeta K, Kim J F et al. Eur J Pharmacol 2002: 448: 175-183.
26. Scholzen T E, Steinhoff M, Sindrilaru A et al. FASEB J 2004: 18: 1007-1009.